Today, Johnson & Johnson MedTech, a leader in neurovascular care, announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the TRUFILL n‑BCA Liquid Embolic ...

J&J wins FDA approval for TRUFILL system to treat chronic subdural hematoma via middle meningeal artery embolization.

Johnson & Johnson MedTech announced that the FDA has approved an expanded indication for the company’s TruFill n-But ...

FDA approves Johnson & Johnson's Rybrevant Faspro for EGFR lung cancer and expands TRUFILL use for chronic subdural hematoma ...

Medtronic (NYSE: MDT) and Johnson & Johnson (NYSE: JNJ) have both announced recent regulatory milestones for liquid embolic ...

Derek Hough's wife, Hayley Erbert, marked the two-year anniversary of her emergency craniectomy with a post reflecting on the ...

Surgical complications left the husband partially paralyzed, requiring a cane to walk, and suffering from uncontrollable leg ...

Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx liquid embolic system demonstrates.

The $27 million verdict includes $5 million in loss of consortium damages for the wife of injured Michael Gerlach. Holmes ...

Two years after Hayley Erbert, who is expecting her first baby with husband Derek Hough, underwent brain surgery for cranial ...

A jury awarded $27 million to a couple who alleged a spinal cord stimulator led to a man’s permanent spine injuries, Florida Today reported Dec. 18. The man was admitted to Holmes Regional Medical ...

December 11, 2025—Medtronic announced that the Onyx liquid embolic system (LES)—Onyx 18 and Onyx 34—is now indicated in the United States for embolization of the middle meningeal artery (MMA) as an ...